drugset / Trial / NCT04831996
To Evaluate the Safety, and Pharmacokinetics of Parscaclisib in Participants With Normal Renal Function and Renal Impairment.
Non-randomizedParallel-groupOpen-labelOther
Summary
The purpose of the study is to evaluate the pharmacokinetics and safety of parsaclisib in participants With normal renal function and participants with renal impairment.
Timeline
- Start
- 2021-05-04
- Primary completion
- 2022-07-08
- Completion
- 2022-07-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Parsaclisib | Small molecule | — | Oral |